PSquared Asset Management AG

Position in ACLX — Arcellx, Inc.

CIK 1623624 ZURICH, V8

Position in ACLX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$6,343,919

New position

Shares Held

55,251

first reported quarter

Ownership

0.094%

of shares outstanding

% of Portfolio

2.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PSquared Asset Management AG holds $39,207,247 across 5 Biotechnology names. ACLX ranks #3 (16.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,101,228	$15,923,756
2	RVMD	Revolution Medicines, Inc.	138,290	$13,448,702
3	ACLX	Arcellx, Inc. This page	55,251	$6,343,919
4	ABVX	Abivax S.A.	16,200	$1,803,870
5	GPCR	Structure Therapeutics Inc.	35,000	$1,687,000

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,343,919	55,251	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.